TAMPA, FL / ACCESS Newswire / July 29, 2025 / The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, ...

Ozempic users are predominently women aged 30 to 75, meaning many are of peri-menopausal and menopausal age, when collagen ...

Watch a subscriber-only conversation on if algorithms can ever be fair.

"RHONJ" alum Lauren Manzo is getting real about her decades-long battle with weight and how she finally found balance.

The deal was Novo Nordisk’s bid to grab back market share from the cheaper, knockoff versions that Hims & Hers and other ...

A busy mother-of-three dropped an impressive four stone in only a matter of months by kicking her £1,200-a-year addiction to ...

ASX companies such as LTR Pharma are finding smarter ways to stretch the value of existing assets and launch into broader ...

While Rosie O’Donnell, 63, made a name for herself as a Broadway star and host of the Emmy-winning talk show The Rosie ...

This peer was Novo Nordisk, which like Eli Lilly sells a popular drug approved specifically for obesity. Eli Lilly's recent popularity is due in no small measure to its plunge into the highly ...

Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) is watching its stock plummet 20% in morning trading after slashing its ...

Investors and analysts say they expect Eli Lilly to report stronger quarterly sales and profit next week than Danish rival ...

Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a ...